538965 — CONCORD DRUGS Balance Sheet
0.000.00%
- IN₹755.00m
- IN₹941.56m
- IN₹452.45m
- 51
- 27
- 87
- 58
Annual balance sheet for CONCORD DRUGS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.01 | 1.66 | 2.4 | 2.23 | 3.46 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 207 | 229 | 158 | 198 | 136 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 360 | 419 | 435 | 446 | 408 |
| Net Property, Plant And Equipment | 132 | 139 | 132 | 127 | 136 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 499 | 564 | 582 | 588 | 651 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 162 | 229 | 216 | 213 | 262 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 231 | 281 | 265 | 250 | 310 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 268 | 284 | 317 | 338 | 341 |
| Total Liabilities & Shareholders' Equity | 499 | 564 | 582 | 588 | 651 |
| Total Common Shares Outstanding |